Prevention of persistent cerebral smooth muscle contraction in response to whole blood.
Using an in vitro system designed to measure arterial constriction, we have demonstrated the importance of platelet function in maintaining cerebral smooth muscle contraction after whole blood injection. We tested two agents, acetyl salicylic acid (ASA) and phthalazinol, both known to interfere with platelet function. In control tests normal rabbit and monkey blood produced a reliable and persistent arterial constriction. In experimental tests blood drawn from animals premedicated with ASA and phthalazinol failed to produce a persistent contraction. These results support the hypothesis that chemicals released during platelet aggregation may be important in persistent vasospasm.
D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D001488:Basilar Artery / Q000187:drug effects / Q000503:physiopathology; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology; D004285:Dogs; D005260:Female; D000882:Haplorhini; D002546:Ischemic Attack, Transient / Q000097:blood* / Q000517:prevention & control; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects / Q000503:physiopathology*; D010793:Phthalazines / Q000494:pharmacology; D011817:Rabbits; D013345:Subarachnoid Hemorrhage / Q000097:blood; D013917:Thrombin / Q000008:administration & dosage; D013928:Thromboxane A2 / Q000097:blood
D010793:Phthalazines; D013928:Thromboxane A2; D013917:Thrombin; D001241:Aspirin